Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry

European Neuropsychopharmacology

Volumn 15, Issue 5, 2005, Pages 533-543

  Arnold, O ^a   Saletu, B ^a   Anderer, P ^a   Assandri, A ^b   Di Padova, C ^c   Corrado, M ^b   Saletu Zyhlarz, G M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Cross Research   (Switzerland)

^c Zambon Group SpA   (Italy)

Author keywords

Antidepressant; EEG mapping; Elderly; Pharmacodynamics; Psychometry; S adenosyl L methionine; SAMe; Tolerability

Indexed keywords

NUTRACEUTICAL; S ADENOSYLMETHIONINE;

ADULT; AGED; AGING; ALPHA RHYTHM; ARTICLE; BRAIN FUNCTION; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL FLICKER FUSION; DELTA RHYTHM; DIASTOLIC BLOOD PRESSURE; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; FATIGUE; FEMALE; HUMAN; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMETRY; PULSE RATE; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; SYSTOLIC BLOOD PRESSURE; THETA RHYTHM;

AGED; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLACEBOS; PSYCHOMETRICS; REFERENCE VALUES; S-ADENOSYLMETHIONINE;

EID: 24044433528     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2005.01.004     Document Type: Article

References (80)

1. K. Abt Descriptive data analysis: a concept between confirmatory and exploratory data analysis Methods Inf. Med. 26 1987 77 88
2. K. Abt Descriptive data analysis (DDA) in quantitative EEG studies D. Samson-Dollfus Statistics and Topography in Quantitative EEG 1988 Elsevier Paris
3. K. Abt Statistical aspects of neurophysiologic topography J. Clin. Neurophysiol. 7 1990 519 534
4. A. Agnoli, V. Andreoli, M. Casacchia, and R. Cerbo Effect of S-adenosyl-l-methionine (SAMe) upon depressive symptoms J. Psychiatr. Res. 13 1976 43 54
5. S. Algeri, E. Catto, M. Curcio, and E. Coll Changes in rat brain noradrenaline and serotonin metabolism after administration of S-adenosylmethionine V. Zappia E. Usdin S. Salvatore Biochemical and Pharmacological Roles of Adenosylmethionine and the Central Nervous System 1979 Pergamon Press New York 81 87
6. P. Anderer, H.V. Semlitsch, B. Saletu, and M.J. Barbanoj Artifact processing in topographic mapping of electroencephalographic activity in neuropsychopharmacology Psychiatry Res. 45 1992 79 93
7. R.J. Baldessarini Neuropharmacology of S-adenosyl-l-methionine Am. J. Med. 83 Suppl. 5A 1987 95S 103S
8. A. Barberi, and C. Pusateri Sugli effetti della S-adenosyl-metionina (SAMe) nelle sindromi depressive Estratto Minerva Psichiatr. 19 1978 235 243
9. K.M. Bell, L. Plon, W.E. Bunney Jr., and S.G. Potkin S-adenosyl- methionine treatment of depression: a controlled clinical trial Am. J. Psychiatry 145 1988 1110 1114
10. Bell, K.M., Plon, L., Bunney Jr., W.E., Potkin, S.G., 1990. Oral S-adenosyl-methionine in the treatment of depression: a double-blind comparison trial. Unpublished results.
11. T. Bottiglieri, T.K. Chary, M. Laundy, M.W. Carney, P. Godfrey, B.K. Toone, and E.H. Reynolds Transmethylation in depression Ala. J. Med. Sci. 25 1988 296 301
12. T. Bottiglieri, P. Godfrey, T. Flynn, M.W.P. Carey, B.K. Toone, and E.H. Reynolds Cerebrospinal fluid S-adenosyl-methionine in depression and dementia: effects of treatment with parenteral and oral S-adenosyl-methionine J. Neurol. Neurosurg. Psychiatry 53 1990 1096 1098
13. M.W.P. Carney Review: neuropharmacology of S-adenosyl-l-methionine Clin. Neuropharmacol. 9 1986 235 243
14. I. Caruso, M. Fumagalli, L. Bocassini, P. Sarzi Puttini, and S. Santandrea Treatment of depression in rheumatoid arthritic patients: a comparison of S-adenosyl-methionine (Samyr) and placebo in a double-blind study Clin. Trials J. 24 1987 305 310
15. R.K. Chawla, H.L. Bonkovsky, and J.T. Galambos Biochemistry and pharmacology of S-adenosyl-methionine and rationale for its use in liver disease Drugs 40 Suppl. 3 1990 91S 110S
16. S. Cimino, G. Vantini, S. Algeri, G. Curatola, C. Pezzoli, and G. Stramentinoli Age-related modification of dopaminergic and β-adrenergic receptor system: restoration to normal activity by modifying membrane fluidity with S-adenosyl-methionine Life Sci. 34 1984 2029 2039
17. 1- and β-adrenoceptors in rat brain Life Eur. J. Pharmacol. 170 1989 201 207
18. V. Coiro, and P.P. Vescovi Controlled study of psychometric performance in abstinent alcoholics: masked comparison of the effects of 15-day intravenous treatments with S-adenosylmethionine or normal saline Curr. Ther. Res. Clin. Exp. 58 1997 575 586
19. M. Curcio, E. Catto, G. Stramentinoli, and S. Algeri Effect of S-adenosyl-l-methionine on serotonin metabolism in rat brain Prog. Neuro-psychopharmacol. 2 1978 65 71
20. D. De Leo S-adenosyl-l-methionine (SAMe) in clinical practice: preliminary report on 75 depressives Curr. Ther. Res. Clin. Exp. 37 1985 658 661
21. R. Delle Chiaie, R. Pancheri, and P. Scapicchio Efficacy and tolerability of oral and intramuscular S-adenosyl-l-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicentre studies Am. J. Clin. Nutr. 76 2002 1172S 1176S (Suppl.)
22. M. Del Vecchio, G. Iorio, M. Cocorullo, L. Vacca, and A. Amati Has SAMe an antidepressant effect? A preliminary trial versus chlorimipramine Riv. Sper. Freniatr. 102 1978 344 358
23. M. De Vanna, and R. Rigamonti Oral S-adenosyl-l-methionine in depression Curr. Ther. Res. Clin. Exp. 52 1992 478 485
24. 3H]-GABA binding in membrane preparations of rat cerebellum J. Neurochem. 41 1983 302 308
25. C. Fazio, V. Andreoli, A. Agnoli, M. Casachia, and R. Cerbo Effetti terapeutici e meccanismo d'azione della S-adenosil-l-metionina (SAM) nelle sindromi depressive Minerva Med. 64 1973 1515 1529
26. H.A. Friedel, K.L. Goa, and P. Benfield S-adenosyl-l-methionine: review of its pharmacological properties and therapeutical potential liver dysfunction and affective disorders in relation to its physiological role in cell metabolism Drugs 38 Suppl. 3 1989 389S 416S
27. J. Grünberger Psychodiagnostik des Alkoholkranken. Ein methodischer Beitrag zur Bestimmung der Organizität in der Psychiatrie 1977 Maudrich Wien
28. J. Grünberger, and B. Saletu Determination of pharmacodynamics of psychotropic drugs by psychometric analysis Prog. Neuro-psychopharmacol. Biol. Psychiatry 4 1980 417 434
29. J. Grünberger, L. Linzmayer, and B. Saletu Klinische Psychodiagnostik mit Hilfe psychophysiologischer Verfahren Clinical psychodiagnostics by means of psychophysiological techniques Wien Med. Wochenschr. 134 1984 29 35
30. J. Grünberger, L. Linzmayer, M. Dietzl, and B. Saletu The effect of biologically active light on the noo- and thymopsyche and on psychophysiological variables in healthy volunteers Int. J. Psychophysiol. 15 1993 27 37
31. W.M. Herrmann, and E. Schärer Das Pharmako-EEG und seine Bedeutung für die klinische Pharmakologie H.P. Kuemmerle G. Hitzenberger K.H. Spitzy Klinische Pharmakologie 4th ed. 1986 Landsberg München 1 71
32. F. Hirata, and J. Axelrod Phospholipid methylation and biological signal transmission Science 209 1980 1082 1090
33. S.E. Hyman, and E.J. Nestler Initiation and adaptation: a paradigm for understanding psychotropic drug action Am. J. Psychiatry 153 1996 151 162
34. T.M. Itil, D.M. Shapiro, E. Eralp, A. Akmann, K.Z. Itil, and C. Garbizu A new brain function diagnostic unit, including the dynamic brain mapping of computer analyzed EEG, evoked potentials and sleep (a new hardware/software system and its application in psychiatry and psychopharmacology) New Trends Exp. Clin. Psychiatry 1 1985 107 177
35. P.G. Janicak, J. Lipinski, J.M. Davis, J.E. Comaty, C. Waternaux, B. Cohen, E. Altman, and R.P. Sharma S-adenosyl-methionine in depression: a literature review and preliminary report Ala. J. Med. Sci. 25 1988 306 331
36. B.L. Kagan, D.L. Sultzer, N. Rosenlicht, and R.H. Gemer Oral S-adenosyl-l-methionine in depression: a double-blind, placebo-controlled trial Am. J. Psychiatry. 147 1990 591 595
37. B. Küfferle, and J. Grünberger Early clinical double-blind study with S-adenosyl-l-methionine: a new potential antidepressant E. Costa G. Racagni Typical and Atypical Antidepressants: Clinical Practice 1982 Raven Press New York 175 180
38. J.F. Lipinski, B.M. Cohen, F. Frankenburg, M. Tohen, C. Waternaux, R. Altesman, B. Jones, and P. Harris Open trial of S-adenosyl-methionine for treatment of depression Am. J. Psychiatry 141 1984 448 450
39. Macher, J.P., 1995. Effects of 800, 1600 and 2400 mg ademetionine and placebo on nocturnal sleep on pharmaco-EEG parameters of young healthy volunteers after multiple oral dosing. Internal report.
40. M. Mantero, P. Pastorino, A. Carolei, and A. Agnoli Controlled double-blind study (SAMe-imipramine) in depressive syndromes Studio controllato in doppio cieco (SAMe-Imipramina) nelle sindromi depressive Estratto Minerva Med. 66 1975 4098 4101
41. M. Matejcek, and J.E. Devos Selected methods of quantitative EEG analysis and their application in psychotropic drug research P. Kellaway I. Peterson Quantitative Analytic Studies in Epilepsy 1976 Raven Press New York 183 205
42. L. Miccoli, V. Porro, and A. Bertolino Comparison between the antidepressant activity of S-adenosyl-methionine (SAMe) and that of some tricyclic drugs Estratto Acta Neurol. 33 1978 243 255
43. D. Mischoulon, and M. Fava Role of S-adenosyl-l-methionine in the treatment of depression: a review of the evidence Am. J. Clin. Nutr. 76 2002 1158S 1161S (Suppl.)
44. G. Muccioli, A. Scordamaglia, S. Bertacco, and R. Di Carlo Effect of S-adenosyl-l-methionine on brain muscarinic receptors of aged rats Eur. J. Pharmacol. 227 1992 293 299
45. G. Muscettola, M. Galzenati, and A. Balbi Same versus placebo: a double-blind comparison in major depressive disorders E. Costa G. Racagni Typical and Atypical Antidepressants: Clinical Practice 1982 Raven Press New York 151 156
46. M. Nguyen, and A. Gregan S-adenosylmethionine and depression Aust. Fam. Physician 31 2002 339 343
47. M.E. Otero-Losada, and M.C. Rubio Acute changes in 5-HT metabolism after S-adenosyl-l-methionine administration Gen. Pharmacol. 20 1989 403 406
48. P. Pancheri, G. Racagni, R. Delle Chiaie, and M. Popoli Nuove acquisizioni sperimentali e cliniche sulla efficacia e tollerabilità della Ademetionina come antidepressivo G. Ital. Psicopatol. 3 1997 1 23
49. P. Pancheri, P. Scapicchio, and R. Delle Chiaie A double-blind, randomized, parallel-group, efficacy and safety study of intramuscular S-adenosyl-l-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder Int. J. Neuropsychopharmacol. 5 2002 287 294
50. J.F. Rosenbaum, M. Fava, W.E. Falk, M.H. Pollak, L.S. Cohen, B.M. Cohen, and G.S. Zubenko The antidepressant potential of oral S-adenosyl-methionine Acta Psychiatr. Scand. 81 1990 432 436
51. B. Saletu Pharmaco-EEG profiles of typical and atypical antidepressants E. Costa G. Racagni Typical and atypical antidepressants: clinical practice 1982 Raven Press New York 257 268
52. B. Saletu, and J. Grünberger Zur Klassifikation und Objektivierung der Pharmakodynamik der Antidepressiva B. Saletu P. Berner Zyklothymie 1983 Excerpta Medica Amsterdam 103 126
53. B. Saletu, and J. Grünberger On acute and chronic CNS effects of antidepressant in normals: neurophysiological, behavioral and pharmacokinetic studies with pirlindol Methods Find. Exp. Clin. Pharmacol. 7 1985 137 151
54. B. Saletu, and J. Grünberger Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG and psychometric analyses J. Clin. Psychiatry 46 3 (Sec. 2) 1985 45 52
55. B. Saletu, J. Grünberger, and L. Linzmayer Is amezinium metilsulfate-a new antihypotensive drug-psychoactive? Comparative quantitative EEG and psychometric trials with desipramine and methamphetamine Curr. Ther. Res. Clin. Exp. 28 1980 800 826
56. B. Saletu, J. Grünberger, L. Linzmayer, and P. Anderer Classification and assessment of pharmacodynamics of SGD-SCHA 1059 (Binodaline) by quantitative EEG and psychometric analyses C. Perris L. v. Knorring D. Kemali Clinical neurophysiological aspects of psychopathological conditions Advances in Biological Psychiatry vol. 4 1980 Karger Basel 140 166
57. B. Saletu, J. Grünberger, P. Rajna, and M. Karobath Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man J. Neural Transm. 49 1980 63 86
58. B. Saletu, J. Grünberger, L. Linzmayer, and K. Taeuber The pharmacokinetics of nominfensine. Comparison of pharmacokinetics and pharmacodynamics using computer pharmaco-EEG Int. Pharmacopsychiatry 17 1982 43 72
59. B. Saletu, J. Grünberger, and P. Rajna Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine Br. J. Clin. Pharmacol. 15 1983 369 384
60. B. Saletu, J. Grünberger, and L. Linzmayer Early clinical pharmacological studies with sercloremine - a novel antidepressant - utilizing pharmacokinetic, pharmaco-EEG and psychometric analyses Drug Dev. Res. 6 1985 19 38
61. B. Saletu, J. Grünberger, and L. Linzmayer On central effects of serotonin re-uptake inhibitors: quantitative EEG and psychometric studies with sertraline and zimelidine J. Neural Transm. 67 1986 241 266
62. B. Saletu, P. Anderer, K. Kinsperger, and J. Grünberger Topographic brain mapping of EEG in neuropsychopharmacology: Part II. Clinical applications (Pharmaco EEG imaging) Methods Find. Exp. Clin. Pharmacol. 9 1987 385 408
63. B. Saletu, J. Grünberger, P. Anderer, L. Linzmayer, H.V. Semlitsch, and G. Magni Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology Br. J. Clin. Pharmacol. 33 1992 589 601
64. B. Saletu, P. Anderer, A. Assandri, W. Prause, M. Hassan Abu-Bakr, E. Lindeck-Pozza, and G.M. Saletu-Zyhlarz Proving central effects of the nutraceutical and supplementary substance S-adenosyl-l-methionine (ademetionine) by pharmaco-EEG mapping B. Saletu F. Krijzer G. Ferber P. Anderer Electrophysiological Brain Research in Preclinical and Clinical Pharmacology and Related Fields-An Update 2000 Facultas Universitätsverlag Wien 182 192
65. B. Saletu, P. Anderer, and R.D. Pascual-Marqui Pharmacodynamics and EEG: II. From EEG-mapping to EEG-tomography B. Saletu F. Krijzer G. Ferber P. Anderer Electrophysiological Brain Research in Preclinical and Clinical Pharmacology and Related Fields-An Update 2000 Facultas Universitätsverlag Wien 157 163
66. B. Saletu, P. Anderer, L. Linzmayer, H.V. Semlitsch, E. Lindeck-Pozza, A. Assandri, C. Di Padova, and G. Saletu-Zyhlarz Pharmacodynamic studies on the central mode of action of S-adenosyl-l-methionine(SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry J. Neural Transm. 109 2002 1505 1526
67. B. Saletu, P. Anderer, C. Di Padova, A. Assandri, and G.M. Saletu-Zyhlarz Electrophysiological neuroimaging of the central effects of S-adenosyl-l-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography Am. J. Clin. Nutr. 76 2002 1162S 1171S (Suppl.)
68. B. Saletu, P. Anderer, G.M. Saletu-Zyhlarz, O. Arnold, and R.D. Pascual-Marqui Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA) Methods Find. Exp. Clin. Pharmacol. Suppl. C 2002 97S 120S
69. G.M. Saletu-Zyhlarz, P. Anderer, L. Linzmayer, H.V. Semlitsch, A. Assandri, W. Prause, M. Hassan Abu-Bakr, E. Lindeck-Pozza, and B. Saletu Visualizing central effects of S-adenosyl-l-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping Int. J. Neuropsychopharmacol. 5 2002 199 215
70. P. Salmaggi, G.M. Bressa, G. Nicchia, M. Coniglio, P. La Greca, and C. Le Gracie Double-blind placebo-controlled study of S-adenosyl-l-methionine in depressed post-menopausal women Psychother. Psychosom. 5 1993 34 40
71. G. Scaggion, L. Baldan, S. Domanin, M. Sivo, I. Cenci, R. Beggio, and G. Castorina Antidepressive action of S-adenosylmethionine compared to nomifensine maleate Azione antidepressiva della SAMe a confronto con il nomifensine maleato Estratto Minerva Psichiatr. 23 1982 93 97
72. R. Scarzella, and A. Appiotti Confronto clinico in doppio cieco della SAMe versus clorimipramina nelle sindromi depressive Riv. Sper. Freniatr. 102 1978 344 358
73. Schuhfried, G., 1997. Wiener Reaktionstest. Version 3.00. Mödling.
74. G. Stramentinoli Various pharmacological aspects of S-adenosylmethionine: an overview Cell Biol. Rev. S1 1987 67 80
75. L.C. Tolbert MAT kinetics in affective disorders and schizophrenia: an account Ala. J. Med. Sci. 25 1988 291 296
76. R. Torta, R. Borio, A. Cicolin, S. Vighetti, and L. Ravizza S-adenosyl-l-methionine normalizes P300 latency in patients with major depression Curr. Ther. Res. Clin. Exp. 55 1994 864 874
77. D. Von Zerssen Die Beschwerden-Liste als Test Therapiewoche 21 1971 1908 1914
78. D. Von Zerssen Die Befindlichkeitsskala: Parallelformen Bf-S und Bf-S′ 1976 Beltz Weinheim
79. D. Von Zerssen, D.M. Koeller, and E.R. Rey Die Befindlichkeitsskala (B-S): Ein einfaches Instrument zur Objektivierung von Befindlichkeitsstö rungen, insbesondere im Rahmen von Längsschnittuntersuchungen Arzneim.-Forsch. (Drug Res.) 20 1970 915 918
80. S. Zanotti, S. Mori, R. Radaelli, J. Perez, G. Racagni, and M. Popoli Modifications in brain cAMP- and calcium/calmodulin-dependent protein kinases induced by treatment with S-adenosylmethionine Neuropharmacology 3 1998 1081 1089